Oscar Health (OSCR) demonstrates potential with 30.8% year-over-year quarterly revenue growth, impressive earnings trajectory, and an attractive 'A' value score. Despite a recent stock decline of 19.6%, the company shows promising financial indicators and maintains a Zacks Rank #3 (Hold).